nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Arginine—ARG2—pancreatic cancer	0.589	1	CbGaD
L-Arginine—NOS3—Doxorubicin—pancreatic cancer	0.137	0.5	CbGbCtD
L-Arginine—NOS2—Doxorubicin—pancreatic cancer	0.137	0.5	CbGbCtD
L-Arginine—Phlebitis superficial—Tamoxifen—pancreatic cancer	0.0115	0.204	CcSEcCtD
L-Arginine—NOS3—umbilical vein—pancreatic cancer	0.00224	0.379	CbGeAlD
L-Arginine—Rash macular—Sunitinib—pancreatic cancer	0.002	0.0355	CcSEcCtD
L-Arginine—L-Ornithine—ARG2—pancreatic cancer	0.00179	1	CrCbGaD
L-Arginine—Platelet count decreased—Tamoxifen—pancreatic cancer	0.00161	0.0286	CcSEcCtD
L-Arginine—Platelet count decreased—Sunitinib—pancreatic cancer	0.00138	0.0245	CcSEcCtD
L-Arginine—Numbness—Tamoxifen—pancreatic cancer	0.00116	0.0205	CcSEcCtD
L-Arginine—Sensory loss—Tamoxifen—pancreatic cancer	0.00111	0.0197	CcSEcCtD
L-Arginine—ASL—digestive system—pancreatic cancer	0.000927	0.156	CbGeAlD
L-Arginine—Skin exfoliation—Tamoxifen—pancreatic cancer	0.000914	0.0163	CcSEcCtD
L-Arginine—Skin exfoliation—Erlotinib—pancreatic cancer	0.000905	0.0161	CcSEcCtD
L-Arginine—Skin necrosis—Epirubicin—pancreatic cancer	0.000902	0.016	CcSEcCtD
L-Arginine—Skin necrosis—Doxorubicin—pancreatic cancer	0.000834	0.0148	CcSEcCtD
L-Arginine—Necrosis—Fluorouracil—pancreatic cancer	0.000824	0.0147	CcSEcCtD
L-Arginine—Swelling—Tamoxifen—pancreatic cancer	0.000788	0.014	CcSEcCtD
L-Arginine—Skin exfoliation—Sunitinib—pancreatic cancer	0.000783	0.0139	CcSEcCtD
L-Arginine—Numbness—Fluorouracil—pancreatic cancer	0.000781	0.0139	CcSEcCtD
L-Arginine—Extravasation—Irinotecan—pancreatic cancer	0.000774	0.0138	CcSEcCtD
L-Arginine—Extravasation—Gemcitabine—pancreatic cancer	0.000754	0.0134	CcSEcCtD
L-Arginine—Sensory loss—Fluorouracil—pancreatic cancer	0.000747	0.0133	CcSEcCtD
L-Arginine—Extravasation—Fluorouracil—pancreatic cancer	0.000742	0.0132	CcSEcCtD
L-Arginine—Injection site reaction—Gemcitabine—pancreatic cancer	0.000654	0.0116	CcSEcCtD
L-Arginine—Skin exfoliation—Gemcitabine—pancreatic cancer	0.000628	0.0112	CcSEcCtD
L-Arginine—SLC7A1—digestive system—pancreatic cancer	0.000607	0.103	CbGeAlD
L-Arginine—ASS1—islet of Langerhans—pancreatic cancer	0.000607	0.102	CbGeAlD
L-Arginine—Necrosis—Docetaxel—pancreatic cancer	0.000595	0.0106	CcSEcCtD
L-Arginine—Extravasation—Docetaxel—pancreatic cancer	0.000535	0.00952	CcSEcCtD
L-Arginine—Swelling—Fluorouracil—pancreatic cancer	0.000532	0.00947	CcSEcCtD
L-Arginine—Sweating—Tamoxifen—pancreatic cancer	0.000514	0.00913	CcSEcCtD
L-Arginine—Lethargy—Fluorouracil—pancreatic cancer	0.000479	0.00852	CcSEcCtD
L-Arginine—Hypoaesthesia—Tamoxifen—pancreatic cancer	0.000478	0.00851	CcSEcCtD
L-Arginine—Injection site reaction—Docetaxel—pancreatic cancer	0.000464	0.00825	CcSEcCtD
L-Arginine—Flushing—Tamoxifen—pancreatic cancer	0.000446	0.00794	CcSEcCtD
L-Arginine—Skin exfoliation—Docetaxel—pancreatic cancer	0.000446	0.00793	CcSEcCtD
L-Arginine—ASS1—pancreas—pancreatic cancer	0.000426	0.072	CbGeAlD
L-Arginine—Hypoaesthesia—Sunitinib—pancreatic cancer	0.00041	0.00729	CcSEcCtD
L-Arginine—Necrosis—Epirubicin—pancreatic cancer	0.000401	0.00714	CcSEcCtD
L-Arginine—Swelling—Docetaxel—pancreatic cancer	0.000384	0.00683	CcSEcCtD
L-Arginine—Flushing—Sunitinib—pancreatic cancer	0.000382	0.0068	CcSEcCtD
L-Arginine—Necrosis—Doxorubicin—pancreatic cancer	0.000371	0.0066	CcSEcCtD
L-Arginine—ASS1—digestive system—pancreatic cancer	0.000364	0.0615	CbGeAlD
L-Arginine—NOS3—digestive system—pancreatic cancer	0.000363	0.0613	CbGeAlD
L-Arginine—Sweating—Irinotecan—pancreatic cancer	0.000362	0.00644	CcSEcCtD
L-Arginine—Extravasation—Epirubicin—pancreatic cancer	0.000361	0.00642	CcSEcCtD
L-Arginine—Sweating—Gemcitabine—pancreatic cancer	0.000353	0.00628	CcSEcCtD
L-Arginine—Haematuria—Gemcitabine—pancreatic cancer	0.000351	0.00624	CcSEcCtD
L-Arginine—Lethargy—Docetaxel—pancreatic cancer	0.000346	0.00615	CcSEcCtD
L-Arginine—Extravasation—Doxorubicin—pancreatic cancer	0.000334	0.00594	CcSEcCtD
L-Arginine—Hyperhidrosis—Tamoxifen—pancreatic cancer	0.00033	0.00587	CcSEcCtD
L-Arginine—Anorexia—Tamoxifen—pancreatic cancer	0.000326	0.00579	CcSEcCtD
L-Arginine—Hypoaesthesia—Fluorouracil—pancreatic cancer	0.000323	0.00575	CcSEcCtD
L-Arginine—Anorexia—Erlotinib—pancreatic cancer	0.000322	0.00573	CcSEcCtD
L-Arginine—Flushing—Irinotecan—pancreatic cancer	0.000315	0.0056	CcSEcCtD
L-Arginine—Injection site reaction—Epirubicin—pancreatic cancer	0.000313	0.00557	CcSEcCtD
L-Arginine—Skin exfoliation—Epirubicin—pancreatic cancer	0.000301	0.00535	CcSEcCtD
L-Arginine—Decreased appetite—Tamoxifen—pancreatic cancer	0.000297	0.00528	CcSEcCtD
L-Arginine—Decreased appetite—Erlotinib—pancreatic cancer	0.000294	0.00522	CcSEcCtD
L-Arginine—Injection site reaction—Doxorubicin—pancreatic cancer	0.00029	0.00515	CcSEcCtD
L-Arginine—Anorexia—Sunitinib—pancreatic cancer	0.000279	0.00496	CcSEcCtD
L-Arginine—Skin exfoliation—Doxorubicin—pancreatic cancer	0.000278	0.00495	CcSEcCtD
L-Arginine—Decreased appetite—Sunitinib—pancreatic cancer	0.000254	0.00452	CcSEcCtD
L-Arginine—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000252	0.00448	CcSEcCtD
L-Arginine—Anaphylactic shock—Irinotecan—pancreatic cancer	0.000241	0.00429	CcSEcCtD
L-Arginine—Anaphylactic shock—Gemcitabine—pancreatic cancer	0.000235	0.00417	CcSEcCtD
L-Arginine—Hypoaesthesia—Docetaxel—pancreatic cancer	0.000233	0.00415	CcSEcCtD
L-Arginine—Lethargy—Epirubicin—pancreatic cancer	0.000233	0.00415	CcSEcCtD
L-Arginine—Hyperhidrosis—Irinotecan—pancreatic cancer	0.000233	0.00414	CcSEcCtD
L-Arginine—SLC22A4—digestive system—pancreatic cancer	0.000232	0.0391	CbGeAlD
L-Arginine—Anaphylactic shock—Fluorouracil—pancreatic cancer	0.000231	0.0041	CcSEcCtD
L-Arginine—Anorexia—Irinotecan—pancreatic cancer	0.00023	0.00409	CcSEcCtD
L-Arginine—Hyperhidrosis—Gemcitabine—pancreatic cancer	0.000227	0.00404	CcSEcCtD
L-Arginine—Tachycardia—Fluorouracil—pancreatic cancer	0.000225	0.00401	CcSEcCtD
L-Arginine—Anorexia—Gemcitabine—pancreatic cancer	0.000224	0.00398	CcSEcCtD
L-Arginine—Anorexia—Fluorouracil—pancreatic cancer	0.00022	0.00391	CcSEcCtD
L-Arginine—Flushing—Docetaxel—pancreatic cancer	0.000218	0.00387	CcSEcCtD
L-Arginine—Vomiting—Tamoxifen—pancreatic cancer	0.000217	0.00386	CcSEcCtD
L-Arginine—Lethargy—Doxorubicin—pancreatic cancer	0.000216	0.00384	CcSEcCtD
L-Arginine—Hypersensitivity—Sunitinib—pancreatic cancer	0.000216	0.00383	CcSEcCtD
L-Arginine—Rash—Tamoxifen—pancreatic cancer	0.000215	0.00383	CcSEcCtD
L-Arginine—Dermatitis—Tamoxifen—pancreatic cancer	0.000215	0.00383	CcSEcCtD
L-Arginine—Vomiting—Erlotinib—pancreatic cancer	0.000215	0.00382	CcSEcCtD
L-Arginine—Headache—Tamoxifen—pancreatic cancer	0.000214	0.00381	CcSEcCtD
L-Arginine—Rash—Erlotinib—pancreatic cancer	0.000213	0.00379	CcSEcCtD
L-Arginine—Dermatitis—Erlotinib—pancreatic cancer	0.000213	0.00379	CcSEcCtD
L-Arginine—Headache—Erlotinib—pancreatic cancer	0.000212	0.00377	CcSEcCtD
L-Arginine—Decreased appetite—Irinotecan—pancreatic cancer	0.00021	0.00373	CcSEcCtD
L-Arginine—Decreased appetite—Gemcitabine—pancreatic cancer	0.000204	0.00363	CcSEcCtD
L-Arginine—Nausea—Tamoxifen—pancreatic cancer	0.000203	0.00361	CcSEcCtD
L-Arginine—Nausea—Erlotinib—pancreatic cancer	0.000201	0.00357	CcSEcCtD
L-Arginine—Decreased appetite—Fluorouracil—pancreatic cancer	0.000201	0.00357	CcSEcCtD
L-Arginine—Vomiting—Sunitinib—pancreatic cancer	0.000186	0.00331	CcSEcCtD
L-Arginine—Rash—Sunitinib—pancreatic cancer	0.000185	0.00328	CcSEcCtD
L-Arginine—Dermatitis—Sunitinib—pancreatic cancer	0.000184	0.00328	CcSEcCtD
L-Arginine—Headache—Sunitinib—pancreatic cancer	0.000183	0.00326	CcSEcCtD
L-Arginine—Hypersensitivity—Irinotecan—pancreatic cancer	0.000178	0.00316	CcSEcCtD
L-Arginine—Nausea—Sunitinib—pancreatic cancer	0.000174	0.00309	CcSEcCtD
L-Arginine—Hypersensitivity—Fluorouracil—pancreatic cancer	0.00017	0.00302	CcSEcCtD
L-Arginine—Sweating—Epirubicin—pancreatic cancer	0.000169	0.003	CcSEcCtD
L-Arginine—Haematuria—Epirubicin—pancreatic cancer	0.000168	0.00299	CcSEcCtD
L-Arginine—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000167	0.00296	CcSEcCtD
L-Arginine—Tachycardia—Docetaxel—pancreatic cancer	0.000163	0.00289	CcSEcCtD
L-Arginine—Anorexia—Docetaxel—pancreatic cancer	0.000159	0.00282	CcSEcCtD
L-Arginine—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000157	0.0028	CcSEcCtD
L-Arginine—Sweating—Doxorubicin—pancreatic cancer	0.000156	0.00278	CcSEcCtD
L-Arginine—Haematuria—Doxorubicin—pancreatic cancer	0.000155	0.00276	CcSEcCtD
L-Arginine—SLC22A5—digestive system—pancreatic cancer	0.000153	0.0259	CbGeAlD
L-Arginine—Vomiting—Irinotecan—pancreatic cancer	0.000153	0.00272	CcSEcCtD
L-Arginine—Rash—Irinotecan—pancreatic cancer	0.000152	0.0027	CcSEcCtD
L-Arginine—Dermatitis—Irinotecan—pancreatic cancer	0.000152	0.0027	CcSEcCtD
L-Arginine—Headache—Irinotecan—pancreatic cancer	0.000151	0.00268	CcSEcCtD
L-Arginine—Vomiting—Gemcitabine—pancreatic cancer	0.000149	0.00265	CcSEcCtD
L-Arginine—Rash—Gemcitabine—pancreatic cancer	0.000148	0.00263	CcSEcCtD
L-Arginine—Dermatitis—Gemcitabine—pancreatic cancer	0.000148	0.00263	CcSEcCtD
L-Arginine—Headache—Gemcitabine—pancreatic cancer	0.000147	0.00262	CcSEcCtD
L-Arginine—Flushing—Epirubicin—pancreatic cancer	0.000147	0.00261	CcSEcCtD
L-Arginine—Vomiting—Fluorouracil—pancreatic cancer	0.000147	0.00261	CcSEcCtD
L-Arginine—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000146	0.00259	CcSEcCtD
L-Arginine—Rash—Fluorouracil—pancreatic cancer	0.000146	0.00259	CcSEcCtD
L-Arginine—Dermatitis—Fluorouracil—pancreatic cancer	0.000145	0.00259	CcSEcCtD
L-Arginine—Decreased appetite—Docetaxel—pancreatic cancer	0.000145	0.00258	CcSEcCtD
L-Arginine—Headache—Fluorouracil—pancreatic cancer	0.000145	0.00257	CcSEcCtD
L-Arginine—Nausea—Irinotecan—pancreatic cancer	0.000143	0.00255	CcSEcCtD
L-Arginine—Nausea—Gemcitabine—pancreatic cancer	0.000139	0.00248	CcSEcCtD
L-Arginine—Nausea—Fluorouracil—pancreatic cancer	0.000137	0.00244	CcSEcCtD
L-Arginine—Flushing—Doxorubicin—pancreatic cancer	0.000136	0.00242	CcSEcCtD
L-Arginine—Hypersensitivity—Docetaxel—pancreatic cancer	0.000123	0.00218	CcSEcCtD
L-Arginine—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000112	0.002	CcSEcCtD
L-Arginine—Tachycardia—Epirubicin—pancreatic cancer	0.00011	0.00195	CcSEcCtD
L-Arginine—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000109	0.00193	CcSEcCtD
L-Arginine—Anorexia—Epirubicin—pancreatic cancer	0.000107	0.0019	CcSEcCtD
L-Arginine—Vomiting—Docetaxel—pancreatic cancer	0.000106	0.00188	CcSEcCtD
L-Arginine—Rash—Docetaxel—pancreatic cancer	0.000105	0.00187	CcSEcCtD
L-Arginine—Dermatitis—Docetaxel—pancreatic cancer	0.000105	0.00187	CcSEcCtD
L-Arginine—Headache—Docetaxel—pancreatic cancer	0.000104	0.00186	CcSEcCtD
L-Arginine—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000104	0.00185	CcSEcCtD
L-Arginine—Tachycardia—Doxorubicin—pancreatic cancer	0.000101	0.0018	CcSEcCtD
L-Arginine—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000101	0.00179	CcSEcCtD
L-Arginine—Anorexia—Doxorubicin—pancreatic cancer	9.91e-05	0.00176	CcSEcCtD
L-Arginine—Nausea—Docetaxel—pancreatic cancer	9.9e-05	0.00176	CcSEcCtD
L-Arginine—Decreased appetite—Epirubicin—pancreatic cancer	9.77e-05	0.00174	CcSEcCtD
L-Arginine—Decreased appetite—Doxorubicin—pancreatic cancer	9.04e-05	0.00161	CcSEcCtD
L-Arginine—Hypersensitivity—Epirubicin—pancreatic cancer	8.28e-05	0.00147	CcSEcCtD
L-Arginine—Hypersensitivity—Doxorubicin—pancreatic cancer	7.66e-05	0.00136	CcSEcCtD
L-Arginine—Vomiting—Epirubicin—pancreatic cancer	7.15e-05	0.00127	CcSEcCtD
L-Arginine—Rash—Epirubicin—pancreatic cancer	7.09e-05	0.00126	CcSEcCtD
L-Arginine—Dermatitis—Epirubicin—pancreatic cancer	7.08e-05	0.00126	CcSEcCtD
L-Arginine—Headache—Epirubicin—pancreatic cancer	7.04e-05	0.00125	CcSEcCtD
L-Arginine—Nausea—Epirubicin—pancreatic cancer	6.68e-05	0.00119	CcSEcCtD
L-Arginine—Vomiting—Doxorubicin—pancreatic cancer	6.61e-05	0.00118	CcSEcCtD
L-Arginine—Rash—Doxorubicin—pancreatic cancer	6.56e-05	0.00117	CcSEcCtD
L-Arginine—Dermatitis—Doxorubicin—pancreatic cancer	6.55e-05	0.00116	CcSEcCtD
L-Arginine—Headache—Doxorubicin—pancreatic cancer	6.51e-05	0.00116	CcSEcCtD
L-Arginine—Nausea—Doxorubicin—pancreatic cancer	6.18e-05	0.0011	CcSEcCtD
L-Arginine—NOS2—Disease—DTX4—pancreatic cancer	5.5e-05	0.000752	CbGpPWpGaD
L-Arginine—NOS2—Spinal Cord Injury—TP53—pancreatic cancer	5.46e-05	0.000746	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—TYMS—pancreatic cancer	5.36e-05	0.000732	CbGpPWpGaD
L-Arginine—NOS2—Disease—PPP2R5B—pancreatic cancer	5.35e-05	0.000732	CbGpPWpGaD
L-Arginine—ASL—Metabolism—APOE—pancreatic cancer	5.26e-05	0.000719	CbGpPWpGaD
L-Arginine—NOS2—Circadian rythm related genes—PTEN—pancreatic cancer	5.22e-05	0.000714	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—PIK3CG—pancreatic cancer	5.19e-05	0.000709	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—KRAS—pancreatic cancer	5.16e-05	0.000705	CbGpPWpGaD
L-Arginine—NOS2—Disease—HEY2—pancreatic cancer	5.15e-05	0.000704	CbGpPWpGaD
L-Arginine—NOS3—Leptin signaling pathway—AKT1—pancreatic cancer	5.14e-05	0.000703	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—CD44—pancreatic cancer	5.14e-05	0.000703	CbGpPWpGaD
L-Arginine—NOS3—Disease—DTX1—pancreatic cancer	5.1e-05	0.000697	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—PPARG—pancreatic cancer	5.01e-05	0.000685	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—IFNA1—pancreatic cancer	4.98e-05	0.000681	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—KRAS—pancreatic cancer	4.87e-05	0.000665	CbGpPWpGaD
L-Arginine—SLC22A5—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	4.85e-05	0.000663	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—PTEN—pancreatic cancer	4.82e-05	0.000659	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—CD44—pancreatic cancer	4.79e-05	0.000655	CbGpPWpGaD
L-Arginine—NOS2—Disease—HEY1—pancreatic cancer	4.77e-05	0.000652	CbGpPWpGaD
L-Arginine—ASL—Metabolism—PIK3CG—pancreatic cancer	4.75e-05	0.000649	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—PIK3CA—pancreatic cancer	4.74e-05	0.000648	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PRSS1—pancreatic cancer	4.72e-05	0.000645	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—IFNA2—pancreatic cancer	4.64e-05	0.000634	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—GCG—pancreatic cancer	4.59e-05	0.000628	CbGpPWpGaD
L-Arginine—ASL—Metabolism—PPARG—pancreatic cancer	4.58e-05	0.000626	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—PIK3CD—pancreatic cancer	4.56e-05	0.000624	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—PIK3CA—pancreatic cancer	4.47e-05	0.000611	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—SRC—pancreatic cancer	4.47e-05	0.000611	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—HRAS—pancreatic cancer	4.38e-05	0.000599	CbGpPWpGaD
L-Arginine—NOS3—Corticotropin-releasing hormone—AKT1—pancreatic cancer	4.37e-05	0.000597	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—APOE—pancreatic cancer	4.36e-05	0.000596	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—STK11—pancreatic cancer	4.32e-05	0.00059	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—STAT3—pancreatic cancer	4.31e-05	0.000589	CbGpPWpGaD
L-Arginine—NOS3—Disease—DTX4—pancreatic cancer	4.27e-05	0.000584	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—PLAU—pancreatic cancer	4.24e-05	0.000579	CbGpPWpGaD
L-Arginine—NOS2—Disease—JAG2—pancreatic cancer	4.23e-05	0.000578	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PRLHR—pancreatic cancer	4.2e-05	0.000574	CbGpPWpGaD
L-Arginine—ASL—Metabolism—PIK3CD—pancreatic cancer	4.17e-05	0.00057	CbGpPWpGaD
L-Arginine—NOS2—Disease—MEN1—pancreatic cancer	4.17e-05	0.00057	CbGpPWpGaD
L-Arginine—NOS3—Disease—PPP2R5B—pancreatic cancer	4.16e-05	0.000568	CbGpPWpGaD
L-Arginine—NOS2—Disease—SLC2A2—pancreatic cancer	4.14e-05	0.000566	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—HRAS—pancreatic cancer	4.14e-05	0.000566	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—ARG2—pancreatic cancer	4.09e-05	0.000559	CbGpPWpGaD
L-Arginine—NOS3—Disease—HEY2—pancreatic cancer	4e-05	0.000547	CbGpPWpGaD
L-Arginine—NOS2—Disease—SHH—pancreatic cancer	3.98e-05	0.000544	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—PIK3CB—pancreatic cancer	3.98e-05	0.000544	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—ACVR1B—pancreatic cancer	3.95e-05	0.00054	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—ZNRF3—pancreatic cancer	3.95e-05	0.00054	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—PTGS2—pancreatic cancer	3.94e-05	0.000539	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—PIK3CG—pancreatic cancer	3.93e-05	0.000538	CbGpPWpGaD
L-Arginine—NOS2—Disease—IAPP—pancreatic cancer	3.93e-05	0.000537	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—EGFR—pancreatic cancer	3.92e-05	0.000536	CbGpPWpGaD
L-Arginine—NOS3—VEGFA-VEGFR2 Pathway—AKT1—pancreatic cancer	3.87e-05	0.000529	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—PPARG—pancreatic cancer	3.8e-05	0.000519	CbGpPWpGaD
L-Arginine—NOS2—Disease—HSPA1B—pancreatic cancer	3.77e-05	0.000515	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—PIK3CG—pancreatic cancer	3.77e-05	0.000515	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—EGF—pancreatic cancer	3.73e-05	0.000509	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—TYMS—pancreatic cancer	3.71e-05	0.000508	CbGpPWpGaD
L-Arginine—NOS3—Disease—HEY1—pancreatic cancer	3.7e-05	0.000506	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—KRAS—pancreatic cancer	3.7e-05	0.000506	CbGpPWpGaD
L-Arginine—NOS3—Signaling by VEGF—AKT1—pancreatic cancer	3.65e-05	0.000499	CbGpPWpGaD
L-Arginine—ASL—Metabolism—PIK3CB—pancreatic cancer	3.64e-05	0.000497	CbGpPWpGaD
L-Arginine—ASL—Metabolism—PTGS2—pancreatic cancer	3.6e-05	0.000493	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—TYMP—pancreatic cancer	3.58e-05	0.000489	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—SSTR3—pancreatic cancer	3.57e-05	0.000488	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—DTX1—pancreatic cancer	3.57e-05	0.000488	CbGpPWpGaD
L-Arginine—NOS2—Circadian rythm related genes—TP53—pancreatic cancer	3.57e-05	0.000487	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—PIK3CD—pancreatic cancer	3.46e-05	0.000473	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—PTEN—pancreatic cancer	3.44e-05	0.00047	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—SSTR1—pancreatic cancer	3.42e-05	0.000468	CbGpPWpGaD
L-Arginine—NOS2—Disease—JAG1—pancreatic cancer	3.38e-05	0.000461	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PPY—pancreatic cancer	3.36e-05	0.000459	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—PIK3CD—pancreatic cancer	3.31e-05	0.000453	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—SSTR2—pancreatic cancer	3.29e-05	0.00045	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—PLAU—pancreatic cancer	3.29e-05	0.00045	CbGpPWpGaD
L-Arginine—NOS3—Disease—JAG2—pancreatic cancer	3.29e-05	0.000449	CbGpPWpGaD
L-Arginine—NOS3—Disease—MEN1—pancreatic cancer	3.24e-05	0.000443	CbGpPWpGaD
L-Arginine—NOS3—Disease—SLC2A2—pancreatic cancer	3.22e-05	0.000439	CbGpPWpGaD
L-Arginine—NOS2—Disease—CD44—pancreatic cancer	3.21e-05	0.000438	CbGpPWpGaD
L-Arginine—NOS2—Disease—HSPA1A—pancreatic cancer	3.18e-05	0.000435	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CCKBR—pancreatic cancer	3.18e-05	0.000435	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—HRAS—pancreatic cancer	3.15e-05	0.00043	CbGpPWpGaD
L-Arginine—ASL—Metabolism—PTEN—pancreatic cancer	3.14e-05	0.00043	CbGpPWpGaD
L-Arginine—NOS3—Disease—SHH—pancreatic cancer	3.09e-05	0.000422	CbGpPWpGaD
L-Arginine—NOS3—Disease—IAPP—pancreatic cancer	3.05e-05	0.000417	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—APOE—pancreatic cancer	3.02e-05	0.000413	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—PIK3CB—pancreatic cancer	3.01e-05	0.000412	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—DTX4—pancreatic cancer	2.99e-05	0.000409	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—GLI1—pancreatic cancer	2.99e-05	0.000409	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—PTGS2—pancreatic cancer	2.99e-05	0.000408	CbGpPWpGaD
L-Arginine—NOS3—Disease—HSPA1B—pancreatic cancer	2.93e-05	0.0004	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—PIK3CG—pancreatic cancer	2.93e-05	0.0004	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PPP2R5B—pancreatic cancer	2.91e-05	0.000398	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—NRP1—pancreatic cancer	2.91e-05	0.000398	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—EGF—pancreatic cancer	2.89e-05	0.000395	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—PIK3CB—pancreatic cancer	2.89e-05	0.000395	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—GLP1R—pancreatic cancer	2.88e-05	0.000394	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—DPYD—pancreatic cancer	2.84e-05	0.000388	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—HEY2—pancreatic cancer	2.8e-05	0.000383	CbGpPWpGaD
L-Arginine—NOS3—EGF/EGFR Signaling Pathway—AKT1—pancreatic cancer	2.78e-05	0.00038	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—GAST—pancreatic cancer	2.74e-05	0.000374	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PIK3CG—pancreatic cancer	2.73e-05	0.000373	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—SLC2A2—pancreatic cancer	2.69e-05	0.000368	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PPARG—pancreatic cancer	2.63e-05	0.00036	CbGpPWpGaD
L-Arginine—NOS3—Disease—JAG1—pancreatic cancer	2.62e-05	0.000358	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—PTEN—pancreatic cancer	2.6e-05	0.000356	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—SCT—pancreatic cancer	2.59e-05	0.000355	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—HEY1—pancreatic cancer	2.59e-05	0.000355	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—PIK3CD—pancreatic cancer	2.57e-05	0.000352	CbGpPWpGaD
L-Arginine—NOS2—Disease—SMAD4—pancreatic cancer	2.53e-05	0.000346	CbGpPWpGaD
L-Arginine—NOS3—Disease—CD44—pancreatic cancer	2.49e-05	0.00034	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CCK—pancreatic cancer	2.47e-05	0.000338	CbGpPWpGaD
L-Arginine—NOS2—Disease—HES1—pancreatic cancer	2.47e-05	0.000338	CbGpPWpGaD
L-Arginine—NOS3—Disease—HSPA1A—pancreatic cancer	2.47e-05	0.000338	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—PIK3CA—pancreatic cancer	2.42e-05	0.000331	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CNR2—pancreatic cancer	2.41e-05	0.00033	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—GLP1R—pancreatic cancer	2.41e-05	0.00033	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PIK3CD—pancreatic cancer	2.4e-05	0.000328	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CCKAR—pancreatic cancer	2.37e-05	0.000324	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—SRC—pancreatic cancer	2.31e-05	0.000316	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—JAG2—pancreatic cancer	2.3e-05	0.000314	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MEN1—pancreatic cancer	2.27e-05	0.00031	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—VEGFA—pancreatic cancer	2.25e-05	0.000308	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—PIK3CB—pancreatic cancer	2.24e-05	0.000307	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—NRAS—pancreatic cancer	2.23e-05	0.000304	CbGpPWpGaD
L-Arginine—ASL—Metabolism—PIK3CA—pancreatic cancer	2.22e-05	0.000303	CbGpPWpGaD
L-Arginine—NOS2—Disease—TERT—pancreatic cancer	2.17e-05	0.000296	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—SHH—pancreatic cancer	2.16e-05	0.000296	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—NOTCH4—pancreatic cancer	2.15e-05	0.000294	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—IAPP—pancreatic cancer	2.14e-05	0.000292	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PIK3CB—pancreatic cancer	2.09e-05	0.000286	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—CD44—pancreatic cancer	2.09e-05	0.000285	CbGpPWpGaD
L-Arginine—NOS2—Disease—HIF1A—pancreatic cancer	2.07e-05	0.000283	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PTGS2—pancreatic cancer	2.07e-05	0.000283	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—TGFB1—pancreatic cancer	2.07e-05	0.000283	CbGpPWpGaD
L-Arginine—NOS2—Disease—TSC2—pancreatic cancer	2.07e-05	0.000282	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PTHLH—pancreatic cancer	2.05e-05	0.00028	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PTCH1—pancreatic cancer	2.05e-05	0.00028	CbGpPWpGaD
L-Arginine—NOS2—Disease—APOE—pancreatic cancer	2.02e-05	0.000276	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—GCG—pancreatic cancer	2e-05	0.000273	CbGpPWpGaD
L-Arginine—AZIN2—Metabolism—AKT1—pancreatic cancer	1.98e-05	0.000271	CbGpPWpGaD
L-Arginine—NOS3—Disease—SMAD4—pancreatic cancer	1.97e-05	0.000269	CbGpPWpGaD
L-Arginine—NOS3—Disease—HES1—pancreatic cancer	1.92e-05	0.000262	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—KRAS—pancreatic cancer	1.92e-05	0.000262	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—STK11—pancreatic cancer	1.88e-05	0.000257	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—SST—pancreatic cancer	1.88e-05	0.000256	CbGpPWpGaD
L-Arginine—NOS2—Disease—NOTCH1—pancreatic cancer	1.87e-05	0.000255	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—PIK3CA—pancreatic cancer	1.84e-05	0.000251	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—JAG1—pancreatic cancer	1.84e-05	0.000251	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—NOTCH3—pancreatic cancer	1.83e-05	0.00025	CbGpPWpGaD
L-Arginine—ASL—Metabolism—AKT1—pancreatic cancer	1.81e-05	0.000248	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PTEN—pancreatic cancer	1.81e-05	0.000247	CbGpPWpGaD
L-Arginine—NOS2—Disease—EGF—pancreatic cancer	1.8e-05	0.000247	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—SRC—pancreatic cancer	1.8e-05	0.000246	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—PIK3CA—pancreatic cancer	1.76e-05	0.000241	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—VEGFA—pancreatic cancer	1.75e-05	0.000239	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CNR1—pancreatic cancer	1.73e-05	0.000237	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—NRAS—pancreatic cancer	1.73e-05	0.000236	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—TP53—pancreatic cancer	1.7e-05	0.000233	CbGpPWpGaD
L-Arginine—NOS3—Disease—TERT—pancreatic cancer	1.68e-05	0.00023	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—GCG—pancreatic cancer	1.67e-05	0.000228	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—HRAS—pancreatic cancer	1.63e-05	0.000223	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—TYMS—pancreatic cancer	1.62e-05	0.000221	CbGpPWpGaD
L-Arginine—NOS3—Disease—HIF1A—pancreatic cancer	1.61e-05	0.00022	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—TGFB1—pancreatic cancer	1.61e-05	0.00022	CbGpPWpGaD
L-Arginine—NOS3—Disease—TSC2—pancreatic cancer	1.6e-05	0.000219	CbGpPWpGaD
L-Arginine—NOS2—Disease—PIK3CD—pancreatic cancer	1.6e-05	0.000219	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—AGTR1—pancreatic cancer	1.59e-05	0.000218	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—STK11—pancreatic cancer	1.57e-05	0.000215	CbGpPWpGaD
L-Arginine—NOS3—Disease—APOE—pancreatic cancer	1.57e-05	0.000215	CbGpPWpGaD
L-Arginine—ARG2—Metabolism—AKT1—pancreatic cancer	1.5e-05	0.000205	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—KRAS—pancreatic cancer	1.49e-05	0.000203	CbGpPWpGaD
L-Arginine—NOS3—Disease—NOTCH1—pancreatic cancer	1.45e-05	0.000198	CbGpPWpGaD
L-Arginine—NOS2—Hemostasis—AKT1—pancreatic cancer	1.44e-05	0.000197	CbGpPWpGaD
L-Arginine—NOS3—Disease—EGF—pancreatic cancer	1.4e-05	0.000191	CbGpPWpGaD
L-Arginine—NOS2—Disease—PIK3CB—pancreatic cancer	1.4e-05	0.000191	CbGpPWpGaD
L-Arginine—NOS2—Disease—PTGS2—pancreatic cancer	1.39e-05	0.000189	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—SMAD4—pancreatic cancer	1.38e-05	0.000188	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—PIK3CA—pancreatic cancer	1.37e-05	0.000187	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—HES1—pancreatic cancer	1.34e-05	0.000184	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—TP53—pancreatic cancer	1.32e-05	0.000181	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—APOE—pancreatic cancer	1.31e-05	0.00018	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—PIK3CA—pancreatic cancer	1.27e-05	0.000174	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—HRAS—pancreatic cancer	1.26e-05	0.000173	CbGpPWpGaD
L-Arginine—NOS3—Disease—PIK3CD—pancreatic cancer	1.25e-05	0.00017	CbGpPWpGaD
L-Arginine—NOS2—Disease—CTNNB1—pancreatic cancer	1.24e-05	0.000169	CbGpPWpGaD
L-Arginine—NOS2—Disease—PTEN—pancreatic cancer	1.21e-05	0.000165	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PIK3CG—pancreatic cancer	1.19e-05	0.000162	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—TERT—pancreatic cancer	1.18e-05	0.000161	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PPARG—pancreatic cancer	1.15e-05	0.000157	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—HIF1A—pancreatic cancer	1.13e-05	0.000154	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—TSC2—pancreatic cancer	1.12e-05	0.000154	CbGpPWpGaD
L-Arginine—NOS2—Disease—SRC—pancreatic cancer	1.12e-05	0.000153	CbGpPWpGaD
L-Arginine—NOS3—Hemostasis—AKT1—pancreatic cancer	1.12e-05	0.000153	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—APOE—pancreatic cancer	1.1e-05	0.00015	CbGpPWpGaD
L-Arginine—NOS3—Disease—PIK3CB—pancreatic cancer	1.09e-05	0.000148	CbGpPWpGaD
L-Arginine—NOS2—Disease—STAT3—pancreatic cancer	1.08e-05	0.000148	CbGpPWpGaD
L-Arginine—NOS2—Disease—NRAS—pancreatic cancer	1.08e-05	0.000147	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—KDR—pancreatic cancer	1.08e-05	0.000147	CbGpPWpGaD
L-Arginine—NOS3—Disease—PTGS2—pancreatic cancer	1.08e-05	0.000147	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PIK3CD—pancreatic cancer	1.04e-05	0.000143	CbGpPWpGaD
L-Arginine—ASS1—Metabolism—AKT1—pancreatic cancer	1.04e-05	0.000142	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—NFKBIA—pancreatic cancer	1.02e-05	0.00014	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—NOTCH1—pancreatic cancer	1.01e-05	0.000139	CbGpPWpGaD
L-Arginine—NOS2—Disease—MYC—pancreatic cancer	1e-05	0.000137	CbGpPWpGaD
L-Arginine—NOS2—Disease—TGFB1—pancreatic cancer	1e-05	0.000137	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PIK3CG—pancreatic cancer	9.92e-06	0.000136	CbGpPWpGaD
L-Arginine—NOS2—Disease—EGFR—pancreatic cancer	9.82e-06	0.000134	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—EGF—pancreatic cancer	9.81e-06	0.000134	CbGpPWpGaD
L-Arginine—NOS3—Disease—CTNNB1—pancreatic cancer	9.63e-06	0.000132	CbGpPWpGaD
L-Arginine—NOS3—Disease—PTEN—pancreatic cancer	9.38e-06	0.000128	CbGpPWpGaD
L-Arginine—NOS2—Disease—KRAS—pancreatic cancer	9.28e-06	0.000127	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PIK3CB—pancreatic cancer	9.09e-06	0.000124	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PTGS2—pancreatic cancer	9.01e-06	0.000123	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PIK3CD—pancreatic cancer	8.72e-06	0.000119	CbGpPWpGaD
L-Arginine—NOS3—Disease—SRC—pancreatic cancer	8.7e-06	0.000119	CbGpPWpGaD
L-Arginine—NOS2—Disease—PIK3CA—pancreatic cancer	8.52e-06	0.000117	CbGpPWpGaD
L-Arginine—NOS3—Disease—STAT3—pancreatic cancer	8.39e-06	0.000115	CbGpPWpGaD
L-Arginine—NOS3—Disease—NRAS—pancreatic cancer	8.37e-06	0.000114	CbGpPWpGaD
L-Arginine—NOS2—Disease—HRAS—pancreatic cancer	7.89e-06	0.000108	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PTEN—pancreatic cancer	7.86e-06	0.000107	CbGpPWpGaD
L-Arginine—NOS3—Disease—MYC—pancreatic cancer	7.8e-06	0.000107	CbGpPWpGaD
L-Arginine—NOS3—Disease—TGFB1—pancreatic cancer	7.78e-06	0.000106	CbGpPWpGaD
L-Arginine—NOS3—Disease—EGFR—pancreatic cancer	7.63e-06	0.000104	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PIK3CB—pancreatic cancer	7.6e-06	0.000104	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CXCL8—pancreatic cancer	7.31e-06	9.99e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—KRAS—pancreatic cancer	7.2e-06	9.85e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CASP3—pancreatic cancer	6.99e-06	9.56e-05	CbGpPWpGaD
L-Arginine—NOS2—Disease—AKT1—pancreatic cancer	6.96e-06	9.52e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CCND1—pancreatic cancer	6.81e-06	9.3e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—CTNNB1—pancreatic cancer	6.74e-06	9.21e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—PIK3CA—pancreatic cancer	6.62e-06	9.05e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MMP9—pancreatic cancer	6.61e-06	9.03e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PTEN—pancreatic cancer	6.57e-06	8.98e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—HRAS—pancreatic cancer	6.12e-06	8.37e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—SRC—pancreatic cancer	6.09e-06	8.33e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—VEGFA—pancreatic cancer	5.93e-06	8.11e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—STAT3—pancreatic cancer	5.88e-06	8.03e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—NRAS—pancreatic cancer	5.86e-06	8.01e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—PIK3CA—pancreatic cancer	5.54e-06	7.58e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—MYC—pancreatic cancer	5.46e-06	7.46e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—TGFB1—pancreatic cancer	5.45e-06	7.44e-05	CbGpPWpGaD
L-Arginine—NOS3—Disease—AKT1—pancreatic cancer	5.41e-06	7.39e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—EGFR—pancreatic cancer	5.34e-06	7.3e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—KRAS—pancreatic cancer	5.05e-06	6.9e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—PIK3CA—pancreatic cancer	4.64e-06	6.34e-05	CbGpPWpGaD
L-Arginine—NOS3—Metabolism—AKT1—pancreatic cancer	4.53e-06	6.19e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—TP53—pancreatic cancer	4.48e-06	6.13e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—HRAS—pancreatic cancer	4.29e-06	5.86e-05	CbGpPWpGaD
L-Arginine—NOS3—Signaling Pathways—AKT1—pancreatic cancer	3.79e-06	5.18e-05	CbGpPWpGaD
